Serum HMGB1 levels are independently associated with glucose clamp-derived measures of insulin resistance in women with PCOS
Open Access
- 31 May 2023
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 46 (12) , 2629-2637
Abstract
Purpose: PCOS is associated with low grade inflammation which could play a role in insulin resistance and ovarian dysfunction. Preliminary findings suggested that serum levels of HMGB1, a cytokine involved in inflammation, might be altered in women with PCOS. Primary aim of this study was to assess whether HMGB1 serum concentrations are associated with PCOS and with the state of insulin resistance of these women. Methods: Sixty women with PCOS, selected to have a similar proportion of subjects with altered or normal insulin sensitivity, and 29 healthy controls were studied. Serum HMGB1 levels were compared in subgroups of PCOS women and controls. In PCOS women, insulin sensitivity was assessed by the glucose clamp technique and HMGB1 was measured at baseline and after acute hyperinsulinemia. Results: HMGB1 levels were similar in women with PCOS and controls and no elements used for diagnosing PCOS were associated with serum HMGB1. However, HMGB1 concentrations were higher in insulin-resistant vs insulin-sensitive PCOS women (p = 0.017), and inversely associated with insulin-induced total and non-oxidative glucose metabolism. In both subgroups of PCOS women, serum HMBG1 levels significantly increased after acute hyperinsulinemia. Conclusions: These data suggest that HMGB1 levels are not associated with PCOS per se, but with insulin resistance. Further research should establish the underlying nature of this relationship, and whether this protein might play a role in the metabolic complications of PCOS.Keywords
Funding Information
- Ministero della Salute (GR-2018-12367635)
- Università degli Studi di Verona
This publication has 29 references indexed in Scilit:
- Divergences in Insulin Resistance Between the Different Phenotypes of the Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2013
- Role of glycogen synthase kinase-3 beta in the inflammatory response caused by bacterial pathogensJournal of Inflammation, 2012
- Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome SocietyHuman Reproduction Update, 2011
- Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysisFertility and Sterility, 2011
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force reportFertility and Sterility, 2009
- Effects of hyperglycemia and insulin therapy on high mobility group box 1 in endotoxin-induced acute lung injury in a rat model*Critical Care Medicine, 2008
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Human Reproduction, 2004
- The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.The Journal of Clinical Endocrinology & Metabolism, 1996
- The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDMDiabetes, 1988
- The theoretical bases of indirect calorimetry: A reviewMetabolism, 1988